Upstart Rises 32%; CVS Health up 15%; SMCI up 12%; Gilead Sciences Jumps 8%

Tiger Newspress
02-12

Upstart Holdings, Inc. shares of the consumer lending platform gained 32% after its first-quarter guidance was stronger than expected. Upstart expects revenue of $200 million for the current quarter, more than the $193.8 million that analysts had penciled in, according to LSEG. Upstart’s fourth-quarter earnings and revenue also beat analysts’ expectations.

SUPER MICRO COMPUTER INC rose 12% after the artificial-intelligence server maker issued strong guidance for fiscal 2026. CEO Charles Liang, in a business update Tuesday, said the company saw fiscal 2025 revenue "in the range of $23.5 billion to $25 billion, paving the way for $40 billion revenue in FY26." The new revenue range for fiscal 2025 was lower than prior guidance for $26 billion to $30 billion, but the $40 billion revenue estimate for fiscal 2026 was well above the current consensus of $29.2 billion. Super Micro also said it expects to be able to file its 10-K with the Securities and Exchange Commission for the year through June 30, and the 10-Q report for the quarter ended in September, by Feb. 25.

CVS Health jumped 15% after the healthcare company posted fourth-quarter earnings that were better than expectations and said it anticipates adjusted earnings in 2025 of between $5.75 and $6 a share, up from $5.42 in 2024, and roughly in line with analysts' consensus.

Gilead Sciences reported fourth-quarter adjusted earnings of $1.90 a share, topping the consensus estimate of $1.74, and it issued guidance for fiscal 2025 that was better than analysts's expectations. The stock was up 8%.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10